The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node

Annals of Surgical Oncology

Volumn 16, Issue 8, 2009, Pages 2245-2251

  Jakub, James W ^a   Huebner, Marianne ^a   Shivers, Steve ^b   Nobo, Christopher ^b   Puleo, Christopher ^c   Harmsen, William S ^a   Reintgen, Douglas S ^b  

^a MAYO CLINIC   (United States)

^b Lakeland Regional Cancer Center   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CHILD; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROGNOSIS; RISK ASSESSMENT; SCHOOL CHILD; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; ULCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67650970109     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0530-5     Document Type: Article

References (27)

1. CM Balch SJ Soon JE Gershenwald 2001 Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 3622 3634
2. Greene FL, Page DL, Fleming ID, et al. Melanoma of the skin in AJCC cancer staging manual. 6th ed. New York: Springer-Verlag, 2002. p. 209-17.
3. DL Morton JF Thompson AJ Cochran 2006 Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 1307 1317
4. Houghton AN, Akerley W, Bickakjian CK, Daud A, Dilawari RA. Melanoma. NCCN clinical practice guidelines in oncology 2009. Available at: http://www.nccn.org/professionals/physician-gls/PDF/melanoma.pdf. Accessed April 13, 2009.
5. James JW, Reintgen D. Regional lymph node surgery for patients with malignant melanoma. In: Rigel DS, Dzubow LM, Reingen DS, Bystryn JC, Marks R, editors. Cancer of the skin. Philadelphia: Elsevier Saunders; 2005. p. 561-71.
6. E Kaplan P Meier 1958 Non-parametric estimation from incomplete observations JASA 53 457 481
7. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. In: Gail KK, Samet JM, Tsiatis A, Wong W, editors. Statistics for biology and health. New York: Springer; 2000. p. 333-45.
8. SE Singletary R Shallenberger FV Guinee CM McBride 1988 Melanoma with metastasis to regional axillary or inguinal lymph nodes: prognostic factors and results of surgical treatment in 714 patients South Med J 81 5 9
9. RR White WE Stanley JL Johnson DS Tyler HF Seigler 2002 Long-term survival in 2, 505 patients with melanoma with regional lymph node metastasis Ann Surg 235 879 887
10. N Cascinelli M Vaglini M Nava 1984 Prognosis of skin melanoma with regional node metastases (stage II) J Surg Oncol 25 240 247
11. MW Kissin DA Simpson D Easton H White G Westbury 1987 Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma Br J Surg 74 1023 1026
12. CP Karakousis MK Seddik R Moore 1980 Prognostic value of lymph node dissection in malignant melanoma Arch Surg 115 719 722
13. AC van Akkooi MG Bouwhuis AN van Geel 2007 Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma Eur J Surg Oncol 33 102 108
14. H Takeuchi H Kitajima Y Kitagawa 2008 Sentinel lymph node as a target of molecular diagnosis of lymphatic micrometastasis and local immunoresponse to malignant cells Cancer Sci 99 441 450
15. M Rinderknecht M Detmar 2008 Tumor lymphangiogenesis and melanoma metastasis J Cell Physiol 216 347 354
16. N Cascinelli E Bombardieri R Bufalino 2006 Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival J Clin Oncol 24 4464 4471
17. JH Lee R Essner H Torisu-Itakura 2004 Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma J Clin Oncol 22 3677 3684
18. JW Jakub DS Reintgen S Shivers S Pendas 2007 Regional node dissection for melanoma: techniques and indication Surg Oncol Clin N Am 16 247 261
19. MS Sabel K Griffith VK Sondak 2005 Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma J Am Coll Surg 201 37 47
20. KM McMasters SL Wong MJ Edwards 2002 Frequency of nonsentinel lymph node metastasis in melanoma Ann Surg Oncol 9 137 141
21. F Roka P Mastan M Binder 2008 Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients Eur J Surg Oncol 34 82 88
22. SL Wong MJ Edwards C Chao 2001 Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate J Am Coll Surg 192 684 689
23. I Satzger B Volker A Meier A Kapp R Gutzmer 2008 Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes Ann Surg Oncol 15 1723 1732
24. RJ Vuylsteke PJ Borgstein PA van Leeuwen 2005 Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma Ann Surg Oncol 12 440 448
25. DL Morton RP Scheri CM Balch 2007 Can completion lymph node dissection be avoided for a positive sentinel node in melanoma? Ann Surg Oncol 14 2437 2439
26. C Cox EL DuPont B Furman 2003 The clinical relevance of positive sentinel nodes only versus positive nonsentinel lymph nodes in breast cancer patients Am J Surg 186 333 336
27. C Ariyan MS Brady M Gonen K Busam D Coit 2009 Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma Ann Surg Oncol 16 186 190